Personal information

Activities

Collapse all

Works (4)

BIRC5 facilitates cisplatin‐chemoresistance in a m6A‐dependent manner in ovarian cancer

Cancer Medicine
2024-01 | Journal article
DOI: 10.1002/cam4.6811
Contributors: Yadan Fan; Yinglian Pan; Liping Jia; Shuzhen Gu; Binxin Liu; Ziman Mei; Chunyan Lv; Haohao Huang; Genhai Zhu; Qingchun Deng
Source: check_circle
Crossref

Pan-cancer landscape of immunology PIWI-interacting RNAs

Computational and Structural Biotechnology Journal
2023 | Journal article
DOI: 10.1016/j.csbj.2023.10.042
Contributors: Dongyi Wan; Ran Li; Haohao Huang; Xiaohua Zhu; Ganxun Li
Source: check_circle
Crossref

LncRNA SEMA3B-AS1 inhibits breast cancer progression by targeting miR-3940/KLLN axis.

Cell death & disease
2022-09-19 | Journal article
DOI: 10.1038/s41419-022-05189-7
PMID: 36123344
PMC: PMC9485163
Contributors: Jin Hu; Huang H; Xi Z; Ma S; Ming J; Dong F; Guo H; Zhang H; Zhao E; Yao G et al.
Source: Self-asserted source
Haohao Huang

Suppression of mitochondrial ROS by prohibitin drives glioblastoma progression and therapeutic resistance.

Nature communications
2021-06-17 | Journal article
DOI: 10.1038/s41467-021-24108-6
PMID: 34140524
PMC: PMC8211793
Contributors: Huang H; Zhang S; Li Y; Liu Z; Mi L; Cai Y; Wang X; Chen L; Ran H; Xiao D et al.
Source: Self-asserted source
Haohao Huang
How many people are using ORCID?